Health care stocks advanced pre-bell Friday with the Health Care Select Sector SPDR Fund (XLV) and iShares Biotechnology ETF (IBB) 0.2% higher recently.
Applied Therapeutics (APLT) said late Wednesday that the US Food and Drug Administration issued a complete response letter indicating the health regulator's decision not to approve the new drug application for govorestat to treat classic galactosemia due to "deficiencies in the clinical application." Applied Therapeutics shares tumbled by over 74% premarket.
RadNet's (RDNT) shares were almost 4% higher after its DeepHealth unit said it received expanded US Food and Drug Administration 510(k) clearance for its SmartMammo mammography software.
TC BioPharm (TCBP) shares were down 12% after the company filed a registration statement with the US Securities and Exchange Commission Wednesday for the potential sale of up to $100 million of securities from time to time in one or more offerings.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。